US biotech Hookipa retracts merger plans with UK company

cafead

Administrator
Staff member
  • cafead   Feb 20, 2025 at 05:52: PM
via After announcing acquisition plans at the beginning of 2025, immunotherapeutics biotech Hookipa Pharma has decided not to buy rare disease company Poolbeg Pharma.

article source